AUBREY CURBOW: Open Payments
NPI 1306543558 · NIXA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 44 payments from 23 companies in 2025. Trend: 2023 $140 · 2024 $151 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $172 |
| Inspire Medical Systems, Inc. | 1 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| United Therapeutics Corporation | 2 | $49 |
| Grifols USA, LLC | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 2 | $36 |
| Viatris Specialty LLC | 2 | $35 |
| Verona Pharma, Inc. | 2 | $32 |
Products named: DUPIXENT, INSPIRE, FASENRA, NUCALA, Prolastin-C Liquid, TEZSPIRE, XYWAV, YUPELRI.
Industry payments across MO — which companies pay providers there.
